Monographie - Moxifloxacin - Stabilis 4.0

Ultimo aggiornamento :
19/11/2024

Antibiotico

Moxifloxacin

Iniezione

Soluzione orale

Stabilità in soluzione

Stabilità in miscela

Fattori che influenzano la stabilità

Compatibilità

metodo di iniezione

Bibliografia

pdf

Struttura chimica

Nome commerciale

Nome commerciale

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Actira	Lussemburgo, Paesi Bassi, Spagna, Svezia
Avalox	Arabia Saudita, Argentina, Australia, Belgio, Brasile, Canada, Chile, Colombia, Danimarca, Ecuador, Emirati Arabi Uniti, Finlandia, Germania, Irlanda, Malaysia, Marocco, Messico, nuova Zelanda, Paesi Bassi, Perù, Romania, Stati Uniti d’America, Svezia, Turchia, Ungheria, Venezuela
Axokine	Venezuela
Mahaflox	India
Mofelox	Turchia
Mofinacin	Romania
Moflaxa	Romania
Moksefen	Turchia
Moksilox	Turchia
Moxacin	Turchia
Moxifix	Turchia
Moxifloxin	Belgio, Germania
Moxifloxina	Romania
Moxifloxino	Chile, Spagna
Muzdil	Spagna
Octegra	Paesi Bassi, Svezia
Pixiriv	Messico
Praiva	Ecuador, Perù
Proflox	Lussemburgo

Bibliografia

Iniezione

Bibliografia : Moxifloxacin

	tipo	pubblicazione
2017	Rivista	Barker B, Feddema S, Rusho WJ, Dengg R. Visual compatibility of vasopressin with other injectable drugs. Am J Health-Syst Pharm 2005 ; 62: 1969-1976.
2145	Rivista	Fernandez-Varon E, Marin P, Espuny A, Villamayor L, Escudero E, Carceles C. Stability of moxifloxacin injection in peritoneal dialysis solution bags (Dianeal PD1 1.36%® and Dianeal PD1 3.86%®). J Clin Pharm Ther 2006 ; 31: 641-643.
2231	Rivista	de Jongh R, Hens R, Basma V, mouton JW, Tulkens PM, Carryn S. Continuous versus intermittent infusion of temocillin, a directed spectrum penicillin for intensive care patients with nosocomial pneumonia: stability, compatibility, population pharmacokinetic studies and breakpoint selection. J Antimicrob Chemother 2008 ; 61, 2: 382-388.
2262	Rivista	Brammer MK, Chan P, Heatherly K, Trusley C, Kupiec TC, Trissel LA, Psathas PA, Gilmor T, Schaufelberger D. Compatibility of doripenem with other drugs during simulated Y-site administratioN Am J Health-Syst Pharm 2008 ; 65: 1261-1265.
2269	Rivista	Chan P, Bishop A, Kupiec TC, Trissel LA, Gole D, Jimidar IM, Vermeersch H. Compatibility of ceftobiprole medocaril with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 2008 ; 65, 16: 1545-1551.
3109	Laboratorio	Moxifloxacine (Izilox®) -Notice information Bayer Schering Pharma 2010
3162	Laboratorio	Moxifloxacine (Izilox®) - Résumé des caractéristiques du produits Bayer HealthCare 2010
3249	Rivista	Singh BM, Dedhiya MG, Dinunzio J, Chan P, Kupiec TC, Trissel LA, Laudano JB. Compatibility of ceftaroline fosamil for injection with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 2011 ; 68: 2163-2169.
3385	Rivista	Raverdi V, Ampe E, Hecq JD, Tulkens PM. Stability and compatibility of vancomycin for administration by continuous infusion. J Antimicrob Chemother 2013 ; 68: 1179-1182.
3865	Rivista	Vicky M, Samit S, Jaymin P, Michael C T. Compatibility of Norepinephrine Bitartrate with Levofloxacin and Moxifloxacin During Simulated Y-site Administration. Int J Pharm Compound 2016 ; 20, 3 : 236-238.
4650	Laboratorio	Ceftobiprole (Zevtera 500 mg powder for concentrate for solution for infusion.) Summary of Product Characteristics, Advanz Pharma updated 4 aug 2021. Advanz Pharma 2021
4758	Rivista	Schmidt J.P, Steppe M. Stability Study and Simultaneous Determination of Norepinephrine, Moxifloxacin, and Piperacillin + Tazobactam Mixtures Applied in Intensive Care Medicine . Curr Pharm Anal 2023 ; 19, 4: 307-316.

Mentions Légales